2021 NEI Synapse Half-Day: September The Cutting Edge of Major Depressive Disorder
List Price: $
Member Price: $

What will you learn during the 2021 September Synapse Half-Day?

The Half-Day on The Cutting Edge of Major Depressive Disorder gives you the latest information on emerging concepts of MDD. PLUS a live Q&A session with expert guests! 

You will additionally receive helpful information and resources from the non-CME events: Scientific Poster Presentation, Industry Symposium, and featured Exhibiting company.  

CME AGENDA (subject to change)

Saturday, September 25, 2021 from 7:00 am - 10:30 am (Pacific Time)

What’s New? Emerging Concepts in the Treatment of MDD 

Learning Objectives:

  • Explore the pros and cons of switching medications in the treatment of major depressive disorder
  • Explore the pros and cons of utilizing adjunct medications in the treatment of major depressive disorder
  • Implement treatment strategies for major depressive disorder that best meet the need of the patient

Hot Topics! The Latest in Psychopharmacology for Major Depressive Disorder

Learning Objectives:

  • Contemplate recently published research that may influence the future of mental health care
  • Prepare to implement novel treatment strategies as they become available


Neuroscience Education Institute (NEI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

MDs and DOs: NEI designates this live internet activity for a maximum of 2.0 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses and Physician Assistants: the ANCC and NCCPA accept organizations accredited by the ACCME as providers of “formally approved continuing education hours” (ANCC) and “Category 1 CME” (NCCPA). The content of this activity that pertains to pharmacology is worth 1.50 continuing education hours of pharmacotherapeutics.